<div id="readability-page-1"><p>Geneos Wealth Management Inc. boosted its stake in  Houlihan Lokey, Inc. (NYSE:HLI - Free Report) by 63.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,430 shares of the financial services provider's stock after buying an additional 12,944 shares during the period. Geneos Wealth Management Inc.'s holdings in Houlihan Lokey were worth $6,016,000 as of its most recent SEC filing.</p><div><p><span></span><span>Get <strong>Houlihan Lokey</strong> alerts:</span></p></div><p>Several other hedge funds and other institutional investors also recently modified their holdings of the company. Trust Co. of Toledo NA OH acquired a new stake in shares of  Houlihan Lokey in the 2nd quarter worth about $34,000.  Brooklyn Investment Group bought a new position in  Houlihan Lokey in the 1st quarter worth about $33,000.  Strategic Wealth Investment Group LLC bought a new position in  Houlihan Lokey in the 2nd quarter worth about $39,000.  Caitong International Asset Management Co. Ltd increased its stake in shares of  Houlihan Lokey by 3,714.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 267 shares of the financial services provider's stock valued at $43,000 after purchasing an additional 260 shares during the period.  Finally, MAI Capital Management raised its holdings in shares of  Houlihan Lokey by 268.0% during the second quarter. MAI Capital Management now owns 368 shares of the financial services provider's stock valued at $66,000 after buying an additional 268 shares during the last quarter. Institutional investors and hedge funds own  78.07% of the company's stock. </p><h2>Analysts Set New Price Targets</h2><p>HLI has been the subject of a number of recent analyst reports. Weiss Ratings  reissued a &#34;buy (b-)&#34; rating on shares of Houlihan Lokey in a report on Monday, December 8th. Zacks Research cut Houlihan Lokey from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Monday, September 29th. BMO Capital Markets assumed coverage on Houlihan Lokey in a report on Friday, October 3rd. They set an &#34;outperform&#34; rating and a $230.00 price target on the stock. Deutsche Bank Aktiengesellschaft began coverage on shares of Houlihan Lokey in a report on Thursday, October 9th. They issued a &#34;hold&#34; rating and a $210.00 price objective for the company. Finally, Morgan Stanley increased their target price on shares of Houlihan Lokey from $192.00 to $213.00 and gave the company an &#34;overweight&#34; rating in a research report on Monday, September 8th. One investment analyst  has rated the stock with a Strong Buy rating, four have given a Buy rating and five have assigned  a Hold rating to the company. Based on data from MarketBeat.com, Houlihan Lokey currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $207.14.</p><p><b>Read Our Latest Stock Report on HLI</b></p><h2>Houlihan Lokey Stock Down 0.4%</h2><p>Shares of Houlihan Lokey stock opened at $179.09 on Monday. The business has a fifty day simple moving average of $183.99 and a 200-day simple moving average of $188.58. Houlihan Lokey, Inc. has a fifty-two week low of $137.99 and a fifty-two week high of $211.78. The firm has a market cap of $12.55 billion, a price-to-earnings ratio of 28.88 and a beta of 0.95. </p><p>Houlihan Lokey (NYSE:HLI - Get Free Report) last issued its quarterly earnings results on Thursday, October 30th. The financial services provider reported $1.84 EPS for the quarter, topping the consensus estimate of $1.69 by $0.15. Houlihan Lokey had a net margin of 16.62% and a return on equity of 24.17%. The firm had revenue of $659.45 million for the quarter, compared to analysts' expectations of $639.08 million. During the same period in the previous year, the business earned $1.46 earnings per share. Houlihan Lokey's revenue for the quarter was up 14.7% compared to the same quarter last year.  Analysts anticipate that  Houlihan Lokey, Inc. will post 5.98 earnings per share for the current fiscal year. </p><h2>Houlihan Lokey Announces Dividend</h2><p>The firm also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Monday, December 1st will be issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Monday, December 1st. Houlihan Lokey's dividend payout ratio (DPR) is presently 38.71%. </p><h2>Insider Transactions at Houlihan Lokey</h2><p>In other Houlihan Lokey news, Chairman Irwin Gold sold 6,811 shares of the company's stock in a transaction on Tuesday, September 16th. The stock was sold at an average price of $202.75, for a total value of $1,380,930.25. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own  22.83% of the company's stock. </p><h2>About Houlihan Lokey</h2> (Free Report)<p>Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&amp;A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Houlihan Lokey</li><li>3 Healthcare Dividend Stocks to Buy</li><li>Dave &amp; Buster’s Reversal Is in PLAY After Double-Bottom Breakout</li><li>When to Sell a Stock for Profit or Loss</li><li>3 Finance Stocks to Buy on Rising 10-Year Treasury Rates</li><li>How to start investing in penny stocks</li><li>Disney's $1 Billion Deal Brings Its Magic to OpenAI</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhMSQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhMSQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Houlihan Lokey Right Now?</h2><p>Before you consider Houlihan Lokey, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Houlihan Lokey wasn't on the list.</p><p>While Houlihan Lokey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Geneos Wealth Management Inc. increased its stake in Houlihan Lokey, Inc. by 63.2% in Q2, owning 33,430 shares worth $6,016,000. Analysts have mixed ratings, with a consensus of "Moderate Buy" and an average target price of $207.14. Houlihan Lokey reported Q3 earnings of $1.84 per share, beating estimates, and announced a quarterly dividend of $0.60 per share.</p>

Houlihan Lokey, Inc. $HLI Stake Lifted by Geneos Wealth Management Inc.